INSP
Inspire Medical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 2
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
RSI Overbought
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About INSP
Inspire Medical Systems, Inc.
A medical technology company focused on proposing solutions for patients with obstructive sleep apnea syndrome (OSA) in the United States and internationally
Healthcare Technology
--
05/03/2018
New York Stock Exchange
1,246
12-31
Common stock
5500 Wayzata Blvd., Suite 1600, Golden Valley, MN 55416
--
Inspire Medical Systems, Inc., was incorporated in Delaware in November 2007. The company is a medical technology company focused on developing and commercializing innovative minimally invasive solutions for patients with obstructive sleep apnea (OSA). The company's proprietary Inspire system is the first and only FDA-approved neurostimulation technology to provide a safe and effective treatment for moderate to severe OSA. The company has developed a novel closed-loop solution that continuously monitors the patient's breathing and provides mild hypoglossal nerve stimulation to maintain an open airway.
Earnings Call
Q2/2025
Estimate EPS0.2
Actual EPS0.45
Estimate Revenue214.34M
Actual Revenue217.10M
Inspire Medical Systems' Q2 2025: Key Contradictions on Revenue Growth, Medicare Billing, and Patient Trends
Aug 04,2025 11:32
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
INSP has released its 2025 Q3 earnings. EPS was reported at 0.38, versus the expected -0.17, beating expectations. The chart below visualizes how INSP has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
INSP has released its 2025 Q3 earnings report, with revenue of 224.50M, reflecting a YoY change of 10.49%, and net profit of 9.93M, showing a YoY change of -46.30%. The Sankey diagram below clearly presents INSP's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
